We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04800627
Brief Title: Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor

First Submitted : January 12, 2021
First Submitted that Met QC Criteria : March 12, 2021
First Posted : March 16, 2021

Last Update Submitted that Met QC Criteria : September 22, 2022
Last Update Posted : September 26, 2022